Artwork

Content provided by DSI, Meranda Parascandola, and Ed Narke. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by DSI, Meranda Parascandola, and Ed Narke or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

001 Expedited Drug Development - James Mencel

18:51
 
Share
 

Manage episode 277251884 series 2821798
Content provided by DSI, Meranda Parascandola, and Ed Narke. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by DSI, Meranda Parascandola, and Ed Narke or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

What We Covered

  • 00:23 – James discusses regulations and the importance of starting with big ideas when it comes to expedited drug development programs
  • 05:44 – Breakthrough designations that occur as a result of expedited drug development programs
  • 08:20 – When a sponsor should consider applying for expedited drug development
  • 11:14 – James speaks to his unique background and experiences with CMC including obstacles and challenges that CMC faces
  • 15:02 – What companies can do to get ahead of the curve when it comes to drug development
  • 18:10 – Ed and Miranda thank James for joining the show

Tweetable Quotes

“When you are in a program that gets expedited, the attention is for the program to move quickly. And there are several ways in which it can move quickly. But almost all of them lead to a very shortened timeframe for CMC. So what it gets you is the FDA’s aware that there is stress on CMC.”

“If you know you’ve got a receptor site – a validated model – some sponsors know from the outset they’re going to approach the FDA even before they go into Phase One because they have a receptor site model. And if they get a model that hits then they’re going to request some sort of expedited status.”

“The first question to ask yourself is, ‘Can this process do the job?’ Because, if this program goes expedited, this process that I’m running right now may be the commercial process whether I like it or not.”

Relevant Links

Leadership - https://dsinpharmatics.com/leadership/#leadership

Project Management - https://dsinpharmatics.com/leadership#projectmanagement

Analytical - https://dsinpharmatics.com/leadership#analytical

Drug Substance - https://dsinpharmatics.com/leadership#drugsubstance

Drug Product - https://dsinpharmatics.com/leadership#drugproduct

Regulatory - https://dsinpharmatics.com/leadership#regulatory

Quality Assurance - https://dsinpharmatics.com/leadership#qualityassurance

Biologics & Microbiology - https://dsinpharmatics.com/leadership#biologics

Formulation & Clinical Ops - https://dsinpharmatics.com/leadership#formulation

Design Space InPharmatics - LinkedIn

Design Space InPharmatics - Twitter

Edward Narke on LinkedIn

  continue reading

27 episodes

Artwork
iconShare
 
Manage episode 277251884 series 2821798
Content provided by DSI, Meranda Parascandola, and Ed Narke. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by DSI, Meranda Parascandola, and Ed Narke or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

What We Covered

  • 00:23 – James discusses regulations and the importance of starting with big ideas when it comes to expedited drug development programs
  • 05:44 – Breakthrough designations that occur as a result of expedited drug development programs
  • 08:20 – When a sponsor should consider applying for expedited drug development
  • 11:14 – James speaks to his unique background and experiences with CMC including obstacles and challenges that CMC faces
  • 15:02 – What companies can do to get ahead of the curve when it comes to drug development
  • 18:10 – Ed and Miranda thank James for joining the show

Tweetable Quotes

“When you are in a program that gets expedited, the attention is for the program to move quickly. And there are several ways in which it can move quickly. But almost all of them lead to a very shortened timeframe for CMC. So what it gets you is the FDA’s aware that there is stress on CMC.”

“If you know you’ve got a receptor site – a validated model – some sponsors know from the outset they’re going to approach the FDA even before they go into Phase One because they have a receptor site model. And if they get a model that hits then they’re going to request some sort of expedited status.”

“The first question to ask yourself is, ‘Can this process do the job?’ Because, if this program goes expedited, this process that I’m running right now may be the commercial process whether I like it or not.”

Relevant Links

Leadership - https://dsinpharmatics.com/leadership/#leadership

Project Management - https://dsinpharmatics.com/leadership#projectmanagement

Analytical - https://dsinpharmatics.com/leadership#analytical

Drug Substance - https://dsinpharmatics.com/leadership#drugsubstance

Drug Product - https://dsinpharmatics.com/leadership#drugproduct

Regulatory - https://dsinpharmatics.com/leadership#regulatory

Quality Assurance - https://dsinpharmatics.com/leadership#qualityassurance

Biologics & Microbiology - https://dsinpharmatics.com/leadership#biologics

Formulation & Clinical Ops - https://dsinpharmatics.com/leadership#formulation

Design Space InPharmatics - LinkedIn

Design Space InPharmatics - Twitter

Edward Narke on LinkedIn

  continue reading

27 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide